| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2017 | PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. | Jiao, S; Xia, W; Yamaguchi, H; Wei, Y; Chen, MK; Hsu, JM; Hsu, JL; Yu, WH; Du, Y; Lee, HH; Li, CW ; Chou, CK; Lim, SO; Chang, SS; Litton, J; Arun, B; Hortobagyi, GN; Hung, MC | Clinical cancer research : an official journal of the American Association for Cancer Research 23(14), 3711-3720 | | | |
| 2017 | Rational combination of immunotherapy for triple negative breast cancer treatment. | Li, CW ; Lim, SO; Hsu, JL; Hung, MC | Chinese clinical oncology 6(5), 54 | | | |
| 2021 | Redox sensor NPGPx restrains ZAP70 activity and modulates T cell homeostasis | Su, FY; Hung, SC; Wei, PC; Su, LW; Hsu, PH; Li, JP; Hsieh, YL; Hu, CM ; Hsu, JL; Yang, CY; Chung, CY; Shew, JY ; Lan, JL; Sytwu, HK; Lee, EY; Lee, WH | Free Radical Biology and Medicine 165, 368-384 | | | |
| 2013 | Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke. | Yu, YL; Chou, RH; Shyu, WC; Hsieh, SC; Wu, CS; Chiang, SY; Chang, WJ; Chen, JN; Tseng, YJ; Lin, YH; Lee, W; Yeh, SP; Hsu, JL; Yang, CC; Hung, SC; Hung, MC | EMBO molecular medicine 5(4), 531-47 | | | |
| 2018 | STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. | Hsu, JM; Xia, W; Hsu, YH; Chan, LC; Yu, WH; Cha, JH; Chen, CT; Liao, HW; Kuo, CW; Khoo, KH ; Hsu, JL; Li, CW; Lim, SO; Chang, SS; Chen, YC; Ren, GX; Hung, MC | Nature communications 9(1), 1908 | | | |
| 2019 | Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cells. | Han, Y; Chen, MK; Wang, HL; Hsu, JL; Li, CW ; Chu, YY; Liu, CX; Nie, L; Chan, LC; Yam, C; Wang, SC; He, GJ; Hortobagyi, GN; Tan, XD; Hung, MC | American journal of cancer research 9(3), 608-618 | | | |
